ALKS
Alkermes Plc
NASDAQ · Healthcare · Biotechnology · IE
$43.39
−7.11%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 65.15x
- P/E 2028E
- 35.83x
- P/S forward
- 3.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- 107.67x
- PEG TTM
- —
- Price / book
- 4.02x
- Price / sales
- 4.36x
- Price / cash flow
- 28.98x
Enterprise value
- Enterprise value
- $8.2B
- EV / sales
- 4.91x
- EV / EBITDA
- 37.59x
- EV / EBIT
- 69.88x
- Market cap
- $7.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026